Cost-effectiveness of the prophylactic HPV vaccine: an application to the Netherlands taking non-cervical cancers and cross-protection into account. [electronic resource]
Producer: 20140421Description: 3922-7 p. digitalISSN:- 1873-2518
- Anus Neoplasms -- prevention & control
- Child
- Cost-Benefit Analysis
- Cross Protection
- Female
- Human papillomavirus 16 -- pathogenicity
- Human papillomavirus 18 -- pathogenicity
- Humans
- Immunization Programs -- economics
- Models, Economic
- Netherlands -- epidemiology
- Oropharyngeal Neoplasms -- economics
- Papillomavirus Infections -- economics
- Papillomavirus Vaccines -- economics
- Uterine Cervical Neoplasms -- economics
- Vaccination -- economics
- Vaginal Neoplasms -- economics
- Vulvar Neoplasms -- economics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.